Skip to main content
. Author manuscript; available in PMC: 2023 Jun 13.
Published in final edited form as: Cancer Cell. 2022 May 26;40(6):609–623.e6. doi: 10.1016/j.ccell.2022.05.005

Figure 2. Clustered heatmap of mechanism-of-action ‘qualifying’ biomarkers across 10 arms.

Figure 2.

Unsupervised clustering of mechanism-of-action biomarkers (rows) and 987 patient samples (columns), with biomarkers annotated by platform and pathway; and samples annotated by HR/HER2, MP1/2 class, response, receptor subtype, PAM50, TN subtypes (7- and 4-classes), and arm. See also Table S1 and S2.